PlainRecalls
FDA Drug Low Class III Terminated

Fentanyl Citrate Injection, USP, 100 mcg/2 mL (50 mcg/mL), 25 Ampules per carton, (2 mL each), Rx only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-030-25

Reported: May 1, 2019 Initiated: April 23, 2019 #D-1241-2019

Product Description

Fentanyl Citrate Injection, USP, 100 mcg/2 mL (50 mcg/mL), 25 Ampules per carton, (2 mL each), Rx only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-030-25

Reason for Recall

Failed impurities/degradation specification: Out of Specification result for total impurity at 4.0% (Limit: NMT 3.0%) at 12 months stability testing.

Details

Recalling Firm
Akorn Inc
Units Affected
5,380 cartons (25 ampules per carton)
Distribution
U.S.A. Nationwide
Location
Lake Forest, IL

Frequently Asked Questions

What product was recalled?
Fentanyl Citrate Injection, USP, 100 mcg/2 mL (50 mcg/mL), 25 Ampules per carton, (2 mL each), Rx only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-030-25. Recalled by Akorn Inc. Units affected: 5,380 cartons (25 ampules per carton).
Why was this product recalled?
Failed impurities/degradation specification: Out of Specification result for total impurity at 4.0% (Limit: NMT 3.0%) at 12 months stability testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 1, 2019. Severity: Low. Recall number: D-1241-2019.